Medicare Administrator Issues Draft Decision Adding Myriad's Prolaris Test to Non-covered Service
September 24, 2012
Medicare Administrator Issues Draft Decision Adding Myriad's Prolaris Test to Non-covered Service
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Myriad, Intermountain Healthcare Partner on MDx Evaluation
May 22, 2012 / GenomeWeb Daily News - Medicare Prices Myriad's BRACAnalysis, Colaris Tests; Firm Confirms Guidance for 2013
March 4, 2013 / GenomeWeb Daily News - Myriad Presents Fourth Study Showing Prolaris Score Predicts Prostate Cancer Aggressiveness
February 8, 2012 / Pharmacogenomics Reporter - Continuing Push to Diversify Offerings, Myriad Licenses Chronix's Early Cancer Detection Technology
May 11, 2011 / Pharmacogenomics Reporter - Myriad Genetics Licenses Cancer Dx Technology from Chronix
May 10, 2011 / GenomeWeb Daily News